Wen-ting Liao

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

A pan-KRAS degrader for the treatment of KRAS-mutant cancers.

A pan-KRAS degrader for the treatment of KRAS-mutant cancers.

Journal: Cell discovery

Published: September 07, 2023

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.

Journal: Nature medicine

Published: July 30, 2023

Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.

Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.

Journal: Frontiers in immunology

Published: May 01, 2022

Histone deacetylase inhibitors attenuated interleukin-1β-induced chondrogenesis inhibition in synovium-derived mesenchymal stem cells of the temporomandibular joint.

Histone deacetylase inhibitors attenuated interleukin-1β-induced chondrogenesis inhibition in synovium-derived mesenchymal stem cells of the temporomandibular joint.

Journal: Bone & joint research

Published: January 27, 2022

Effects of interleukin 1β on long noncoding RNA and mRNA expression profiles of human synovial fluid derived mesenchymal stem cells.

Effects of interleukin 1β on long noncoding RNA and mRNA expression profiles of human synovial fluid derived mesenchymal stem cells.

Journal: Scientific reports

Published: November 21, 2021

Retraction Note to: High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer.

Retraction Note to: High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer.

Journal: BMC gastroenterology

Published: October 12, 2021

Telomere dysfunction activates YAP1 to drive tissue inflammation.

Telomere dysfunction activates YAP1 to drive tissue inflammation.

Journal: Nature communications

Published: February 10, 2020

Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment.

Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment.

Journal: Cancer discovery

Published: March 09, 2019

UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer.

UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer.

Journal: Cancer cell international

Published: November 14, 2018

Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.

Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 23, 2018

miR-422a inhibits cell proliferation in colorectal cancer by targeting AKT1 and MAPK1.

miR-422a inhibits cell proliferation in colorectal cancer by targeting AKT1 and MAPK1.

Journal: Cancer cell international

Published: July 31, 2017

Oncogenic Kras drives invasion and maintains metastases in colorectal cancer.

Oncogenic Kras drives invasion and maintains metastases in colorectal cancer.

Journal: Genes & development

Published: November 05, 2016

Showing 1-12 of 27

Last Updated: 09/26/2026